SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-062165
Filing Date
2024-03-07
Accepted
2024-03-07 16:05:27
Documents
2
Group Members
HEALTHCAP VII GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d751100dsc13da.htm SC 13D/A 47160
2 EX-99.1(07) d751100dex99107.htm EX-99.1(07) 6140
  Complete submission text file 0001193125-24-062165.txt   55112
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87951 | Film No.: 24730040
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018
Business Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018 41 21 614 3500
HealthCap VII, L.P. (Filed by) CIK: 0001645161 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A